{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-026518","form_type":"8-K","ticker":"ALKS","cik":"0001520262","company_name":"Alkermes plc.","filed_at":"2023-06-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:39.221265+00:00","generated_at":"2026-06-14T06:35:49.369870+00:00","sec_items":["7.01","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Alkermes wins arbitration vs Janssen, raises 2023 outlook by ~$425M","bullets":["Final arbitration award confirms Janssen must pay royalties on INVEGA and CABENUVA products; back royalties of ~$194M (incl. interest) received.","2023 total revenue guidance raised to $1.55B-$1.68B from $1.13B-$1.25B; GAAP net income now $225M-$265M vs prior loss.","Royalty terms clarified: INVEGA SUSTENNA until Aug 2024, INVEGA TRINZA until Q2 2030, INVEGA HAFYERA until May 2030, CABENUVA until Dec 2036.","Non-GAAP net income guidance raised to $230M-$270M from $0M-$40M; back royalties excluded from non-GAAP.","Company reiterates FY2024/2025 profitability targets (25%/30% non-GAAP net income margin) excluding Janssen royalties."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-026518","json":"https://secwatch.observer/filing/0000950170-23-026518.json","markdown":"https://secwatch.observer/filing/0000950170-23-026518.md","text":"https://secwatch.observer/filing/0000950170-23-026518.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1520262/000095017023026518/0000950170-23-026518-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1520262/000095017023026518/alks-20230531.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T06:35:49.369870+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}